A detailed history of Simplex Trading, LLC transactions in Rezolute, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 21,701 shares of RZLT stock, worth $215,056. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,701
Previous 8,634 151.34%
Holding current value
$215,056
Previous $38,000 434.21%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$4.42 - $9.34 $57,756 - $122,045
13,067 Added 151.34%
21,701 $203,000
Q2 2025

Aug 05, 2025

BUY
$2.47 - $4.46 $21,246 - $38,364
8,602 Added 26881.25%
8,634 $38,000
Q1 2025

May 12, 2025

SELL
$2.73 - $5.57 $4,403 - $8,984
-1,613 Reduced 98.05%
32 $0
Q4 2024

Feb 11, 2025

BUY
$4.08 - $5.96 $6,711 - $9,804
1,645 New
1,645 $7,000
Q2 2024

Jul 25, 2024

BUY
$2.29 - $5.79 $366 - $926
160 New
160 $0

Others Institutions Holding RZLT

About Rezolute, Inc.


  • Ticker RZLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,600
  • Market Cap $385M
  • Description
  • Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...
More about RZLT
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.